General Information
Version
1.0 en
Revision date
2025-03-10
Product name
D-(-)-3-Phosphoglyceric acid disodium ≥95 %
CAS No.
80731-10-8
1.2.1 Relevant identified uses
Laboratory and analytical use
1.2.2. Uses advised against
Do not use for products which come into contact with foodstuffs. Do not use for private purposes (household). Food, drink and animal feeding- stuffs
Emergency telephone
+49/(0)89 19240
Icons in SDS
Company Information
company name
Carl Roth GmbH + Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
sicherheit@carlroth.de
GHS Information
Signal word
Not required
Hazard Codes
Hazard statements (CLP)
H315, H319, H335, H371
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture
Hazard categories
Cat- Hazard class and Hazard egory category statement 3.2 Skin corrosion/irritation Skin Irrit. 2 H315 3.3 Serious eye damage/eye irritation Eye Irrit. 2 H319 3.8 Specific target organ toxicity - single exposure STOT SE 2 H371 Section Cat- Hazard class and Hazard egory category statement 3.8R Specific target organ toxicity - single exposure (respir- STOT SE 3 H335 atory tract irritation) For full text of abbreviations: see SECTION 16
Most important adverse effects
Immediate effects can be expected after short-term exposure
Signal word
Warning Not required
Hazard pictograms
GHS07, GHS08 H335 May cause respiratory irritation. Labelling of packages where the contents do not exceed 10 ml
Hazard statements
H315 Causes skin irritation H319 Causes serious eye irritation H335 May cause respiratory irritation H371 May cause damage to organs Not required
Prevention
P280 Wear protective gloves/eye protection
Response
P302+P352 IF ON SKIN: Wash with plenty of water P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P337+P313 If eye irritation persists: Get medical advice/attention Labelling of packages where the contents do not exceed 125 ml
Precautionary statements
Not required
Results of PBT and vPvB assessment
According to the results of its assessment, this substance is not a PBT or a vPvB. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 (CLP) Section Hazard class Cat- Hazard class and Hazard egory category statement 3.2 Skin corrosion/irritation 2 Skin Irrit. 2 H315 3.3 Serious eye damage/eye irritation 2 Eye Irrit. 2 H319 3.8 Specific target organ toxicity - single exposure 2 STOT SE 2 H371 Section Hazard class Cat- Hazard class and Hazard egory category statement 3.8R Specific target organ toxicity - single exposure (respir- 3 STOT SE 3 H335 atory tract irritation) For full text of abbreviations: see SECTION 16 The most important adverse physicochemical, human health and environmental effects Immediate effects can be expected after short-term exposure.
